Columbia University-Naomi Berrie Diabetes Center

New York, New York 10032

0 studies enrolling now · 9 studies all time

What they study most

Comparative Effectiveness of Glycemia-lowering Medications, Diabetes Mellitus, Type 1, New-onset Type 1 Diabetes Mellitus, T1D, T1DM, Type 1 Diabetes, Type 1 Diabetes Mellitus, Type 2 Diabetes

Studies at this site

• Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D) — Running, not enrolling
• STOP-T1D Low-Dose (ATG) — Stopped early
• A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes — Completed
• Tocilizumab (TCZ) in New-onset Type 1 Diabetes — Completed
• TODAY2 Phase 2 Follow-up — Completed
• Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20) — Completed
• Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus — Completed
• ATG-GCSF in New Onset Type 1 Diabetes — Completed
• Wireless Innovation for Seniors With Diabetes Mellitus — Completed